Healthpeak Properties, Inc. $DOC Shares Sold by Keybank National Association OH

Keybank National Association OH lowered its position in Healthpeak Properties, Inc. (NYSE:DOC) by 39.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 73,240 shares of the real estate investment trust’s stock after selling 47,254 shares during the period. Keybank National Association OH’s holdings in Healthpeak Properties were worth $1,203,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Argent Advisors Inc. increased its stake in shares of Healthpeak Properties by 5.4% in the first quarter. Argent Advisors Inc. now owns 76,153 shares of the real estate investment trust’s stock worth $1,251,000 after acquiring an additional 3,922 shares during the period. IFM Investors Pty Ltd lifted its position in Healthpeak Properties by 1.4% during the first quarter. IFM Investors Pty Ltd now owns 258,497 shares of the real estate investment trust’s stock valued at $4,247,000 after purchasing an additional 3,544 shares during the period. Rexford Capital Inc. boosted its holdings in Healthpeak Properties by 125.0% in the first quarter. Rexford Capital Inc. now owns 3,600 shares of the real estate investment trust’s stock valued at $59,000 after purchasing an additional 2,000 shares during the last quarter. Inspire Investing LLC boosted its holdings in Healthpeak Properties by 11.1% in the first quarter. Inspire Investing LLC now owns 22,647 shares of the real estate investment trust’s stock valued at $372,000 after purchasing an additional 2,265 shares during the last quarter. Finally, Intrua Financial LLC grew its position in Healthpeak Properties by 1.1% during the 1st quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock worth $1,096,000 after purchasing an additional 744 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on DOC shares. Wells Fargo & Company lifted their price objective on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. raised their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Citigroup lifted their price target on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. UBS Group boosted their price target on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Finally, Robert W. Baird upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $20.35.

Healthpeak Properties Price Performance

Shares of DOC stock traded up $0.20 during mid-day trading on Tuesday, hitting $21.95. 230,440 shares of the stock were exchanged, compared to its average volume of 8,992,878. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.04. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The company has a market cap of $15.14 billion, a PE ratio of 68.58, a price-to-earnings-growth ratio of 3.41 and a beta of 1.02. The firm has a fifty day moving average of $19.65 and a 200 day moving average of $17.89.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.